Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions

Aarav Badani, Ahmad Ozair, Mustafa Khasraw, Graeme F. Woodworth, Pallavi Tiwari, Manmeet S. Ahluwalia, Alireza Mansouri

Open source

DOI
10.1007/s11060-024-04881-2
Published
2024-11-21
Container
Journal of Neuro-Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11060-024-04881-2,
  title = {Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions},
  author = {Aarav Badani and Ahmad Ozair and Mustafa Khasraw and Graeme F. Woodworth and Pallavi Tiwari and Manmeet S. Ahluwalia and Alireza Mansouri},
  year = {2024},
  journal = {Journal of Neuro-Oncology},
  doi = {10.1007/s11060-024-04881-2},
  url = {https://doi.org/10.1007/s11060-024-04881-2}
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions
AU  - Aarav Badani
AU  - Ahmad Ozair
AU  - Mustafa Khasraw
AU  - Graeme F. Woodworth
AU  - Pallavi Tiwari
AU  - Manmeet S. Ahluwalia
AU  - Alireza Mansouri
PY  - 2024
JO  - Journal of Neuro-Oncology
DO  - 10.1007/s11060-024-04881-2
UR  - https://doi.org/10.1007/s11060-024-04881-2
ER  - 

APA

Badani, A., Ozair, A., Khasraw, M., Woodworth, G. F., Tiwari, P., Ahluwalia, M. S., & Mansouri, A. (2024). Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04881-2

Source records